This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Alcohol Dependence
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

A 12-week, double-blind, placebo-controlled parallel group study will be conducted with 150 outpatients with alcohol dependence, with random assignment to pregabalin 300 mg/d, duloxetine 40 mg/d, or placebo in conjunction with manual-guided behavioral counseling and follow-up visits 1 week and 3 months post-treatment.

Provided treatments

  • Drug: Pregabalin
  • Drug: Duloxetine
  • Behavioral: Standardized behavioral therapy
  • Behavioral: Standardized behavioral therapy
  • Drug: Placebo
  • Behavioral: Standardized behavioral therapy
Tris trial is registered with FDA with number: NCT00929344. The sponsor of the trial is The Scripps Research Institute and it is looking for 150 volunteers for the current phase.
Official trial title:
Duloxetine Versus Pregabalin for Alcohol Dependence